Data as of Jan 23
| -0.05 / -1.71%|
The 5 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +196.17% increase from the last price of 2.87.
The current consensus among 5 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.